Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Machine learning, artificial intelligence, and data science breaking into drug design and neglected diseases

Peña‐Guerrero J, Nguewa PA, García‐Sosa AT. Wiley. WIREs Computational Molecular Science. 2021;
Publication

Dogs as a model for chemotherapy of Chagas disease and Leishmaniasis.

de Lana M, Giunchetti R. Current pharmaceutical design. 2020;
Publication

Healthcare costs’ reduction through the integration of Healthcare 4.0 technologies in developing economies

Tortorella GL, Fogliatto FS, Espôsto KF, et al. Informa UK Limited. Total Quality Management & Business Excellence. 2020;
Publication

Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.

Njomo D, Kimani B, Kibe L, et al. PLoS neglected tropical diseases. 2020; 14 (12) : e0009012.
Download PDF
Publication

Systematic review of the incidence of post-operative trichiasis in Africa

Mwangi G, Courtright P, Solomon AW. Springer Science and Business Media LLC. BMC Ophthalmology. 2020;
Download PDF
Publication

Severely stigmatised skin neglected tropical diseases: a protocol for social science engagement

Zaman S, Nahar P, MacGregor H, et al. Oxford University Press (OUP). Transactions of The Royal Society of Tropical Medicine and Hygiene. 2020; 114 (12) : 1013-1020.
Download PDF
Publication

Psychosocial impact of skin diseases: A population-based study

Yew YW, Kuan AHY, Ge L, et al. Public Library of Science (PLoS). PLOS ONE. 2020; 15 (12) : e0244765.
Download PDF
Publication

The Trojan Horse: Digital Health, Human Rights, and Global Health Governance.

Davis S. Health and human rights. 2020; 22 (2) : 41-47.
Download PDF
Publication

Neglected tropical diseases activities in Africa in the COVID-19 era: the need for a "hybrid" approach in COVID-endemic times.

Molyneux DH, Bush S, Bannerman R, et al. Infectious diseases of poverty. 2021; 10 (1) : 1.
Download PDF
Publication

The winding road to health: A systematic scoping review on the effect of geographical accessibility to health care on infectious diseases in low- and middle-income countries

Hierink F, Okiro EA, Flahault A, et al. Public Library of Science (PLoS). PLOS ONE. 2021; 16 (1) : e0244921.
Download PDF

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 441
  • Page 442
  • Page 443
  • Page 444
  • Current page 445
  • Page 446
  • Page 447
  • Page 448
  • Page 449
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD